文献速递乳腺技术与安全MR乳腺X线

风险类别和筛查轮次对BRCA突变携带者及其他高危女性MR成像与乳腺X线摄影筛查项目性能的影响

Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.
PubMed 文献 · Radiology · 2017-10-16

该研究评估了2003年1月1日至2014年1月1日期间在大型筛查人群中进行的乳腺癌高危女性筛查(MR成像和乳腺X线摄影)的真实性能。共2463名女性接受了8818次MR和6245次乳腺X线摄影检查,发现170例癌症,其中筛查检出129例、间期癌16例、预防性乳房切除术中发现25例。总体敏感度为75.9%(包括预防性乳房切除术中发现的癌症,95%CI:69.5%,82.4%),排除这些癌症后为90.0%(95%CI:83.3%,93.7%)。BRCA1突变携带者敏感度最低(包括和不包括预防性乳房切除术标本中的癌症分别为66.1%和81.3%)。随访轮次特异度(96.5%;95%CI:96.0%,96.9%)高于首轮(85.1%;95%CI:83.4%,86.5%),MR成像(97.1%;95%CI:96.7%,97.5%)和乳腺X线摄影(98.7%;95%CI:98.3%,99.0%)特异度均高。仅有一级亲属乳腺癌家族史的女性召回阳性预测值和活检阳性预测值最低。结论:筛查性能取决于风险类别,BRCA1突变携带者敏感度最低,高危乳腺癌筛查的特异度在随访轮次中改善。

要点

  • 总体敏感度包括预防性乳房切除术中发现的癌症为75.9%(95%CI:69.5%,82.4%),排除后为90.0%(95%CI:83.3%,93.7%)。
  • BRCA1突变携带者敏感度最低,包括和不包括预防性乳房切除术标本中的癌症分别为66.1%和81.3%。
  • 随访轮次特异度(96.5%;95%CI:96.0%,96.9%)高于首轮(85.1%;95%CI:83.4%,86.5%)。

核心结论

  • 筛查性能取决于风险类别,BRCA1突变携带者敏感度最低。
  • 高危乳腺癌筛查的特异度在随访轮次中改善。

研究设计与样本

  • 研究类型为在学术医院大型筛查人群中进行的筛查项目真实性能评估,评估2003年1月1日至2014年1月1日期间的高危女性筛查检查。
  • 共纳入2463名女性,进行了8818次MR检查和6245次乳腺X线摄影检查。
  • 记录了风险类别、年龄、筛查检出异常的召回、活检和组织病理学诊断;参考标准为组织病理学诊断。

诊断标准与关键数值

  • 总体敏感度包括预防性乳房切除术中发现的癌症为75.9%(95%CI:69.5%,82.4%),排除后为90.0%(95%CI:83.3%,93.7%)。
  • BRCA1突变携带者敏感度包括和不包括预防性乳房切除术标本中的癌症分别为66.1%和81.3%。
  • 随访轮次特异度为96.5%(95%CI:96.0%,96.9%),首轮为85.1%(95%CI:83.4%,86.5%)。
  • MR成像特异度为97.1%(95%CI:96.7%,97.5%),乳腺X线摄影特异度为98.7%(95%CI:98.3%,99.0%)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate the real-life performance of a breast cancer screening program for women with different categories of increased breast cancer risk with multiple follow-up rounds in an academic hospital with a large screening population. Materials and Methods Screening examinations (magnetic resonance [MR] imaging and mammography) for women at increased breast cancer risk (January 1, 2003, to January 1, 2014) were evaluated. Risk category, age, recall for workup of screening-detected abnormalities, biopsy, and histopathologic diagnosis were recorded. Recall rate, biopsy rate, positive predictive value of recall, positive predictive value of biopsy, cancer detection rate, sensitivity, and specificity were calculated for first and follow-up rounds. Results There were 8818 MR and 6245 mammographic examinations performed in 2463 women. Documented were 170 cancers; of these, there were 129 screening-detected cancers, 16 interval cancers, and 25 cancers discovered at prophylactic mastectomy. Overall sensitivity was 75.9% including the cancers discovered at prophylactic mastectomy (95% confidence interval: 69.5%, 82.4%) and 90.0% excluding those cancers (95% confidence interval: 83.3%, 93.7%). Sensitivity was lowest for carriers of the BRCA1 mutation (66.1% and 81.3% when including and not including cancers in prophylactic mastectomy specimens, respectively). Specificity was higher at follow-up (96.5%; 95% confidence interval: 96.0%, 96.9%) than in first rounds (85.1%; 95% confidence interval: 83.4%, 86.5%) and was high for both MR imaging (97.1%; 95% confidence interval: 96.7%, 97.5%) and mammography (98.7%; 95% confidence interval: 98.3%, 99.0%). Positive predictive value of recall and positive predictive value of biopsy were lowest in women who had only a family history of breast cancer. Conclusion Screening performance was dependent on risk category. Sensitivity was lowest in carriers of the BRCA1 mutation. The specificity of high-risk breast screening improved at follow-up rounds. © RSNA, 2017 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Vreemann S, Gubern-Mérida A, Schlooz-Vries MS, et al. Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk. Radiology. 2017. PMID: 29040037. doi:10.1148/radiol.2017170458

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。